Nanoliposomes, or submicron bilayer phospholipid vesicles, are a novel tool to encapsulate
and deliver the active pharmaceutical ingredients. The listing of active substances for integration into
nanoliposomes is enormous, varying from pharmaceuticals to nutraceuticals and cosmetics. Due to
their biocompatible and biodegradable nature, besides their nanosize, nanoliposomes have applications
in diverse areas, like cancer nanotherapy, cosmetics, gene delivery and agricultural food technology.
Nanoliposomes have the capability of improving the efficacy of active agents by recuperating there in
vitro-in vivo solubility, bioavailability, stability and prevent unnecessary interactions between molecules.
Targeting by nanoliposomes depends on the types of the cells to achieve active drug concentrations
for favorable therapeutic effectiveness at the desired target site and minimizing undesirable effects
on healthy tissues and cells. This article sums up the existing studies that have described the
nanoliposomal particles as carriers to transport a variety of pharmaceutical agents, properties, methods
of preparation, and analysis.
Keywords: Docetaxel, doxorubicin, gene delivery, magnetic, nanoliposome, PEG, tumor.
Rights & PermissionsPrintExport